Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Antía Moreira"'
Autor:
Ana Zabalza, Andrea Vera, Elisenda Alari-Pahissa, Elvira Munteis, Antía Moreira, Jose Yélamos, Mireia Llop, Miguel López-Botet, Jose E. Martínez-Rodríguez
Publikováno v:
Journal of Neuroinflammation, Vol 17, Iss 1, Pp 1-8 (2020)
Abstract Background Human cytomegalovirus (HCMV) infection has been recently associated with a low risk of multiple sclerosis (MS), yet the basis behind this observation remains uncertain. In this study, we aimed to determine in MS patients whether H
Externí odkaz:
https://doaj.org/article/31965209bd944d72b64294f56c394027
Autor:
Antía Moreira, Elisenda Alari-Pahissa, Elvira Munteis, Andrea Vera, Ana Zabalza, Mireia Llop, Noelia Villarrubia, Marcel Costa-García, Roberto Álvarez-Lafuente, Luisa María Villar, Miguel López-Botet, Jose E. Martínez-Rodríguez
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Human cytomegalovirus (HCMV) has been recently related with a lower susceptibility to multiple sclerosis (MS). HCMV promotes an adaptive development of NK cells bearing the CD94/NKG2C receptor with a characteristic phenotypic and functional profile.
Externí odkaz:
https://doaj.org/article/784eac7379624904b492e7adf265afe5
Autor:
Adrià Macias-Gómez, Antoni Suárez-Pérez, Ana Rodríguez-Campello, Eva Giralt-Steinhauer, Antía Moreira, Daniel Guisado-Alonso, Jaume Capellades, Isabel Fernández-Pérez, Jordi Jiménez-Conde, Lucía Rey, Joan Jiménez-Balado, Jaume Roquer, Ángel Ois, Elisa Cuadrado-Godia
Publikováno v:
Neurological Sciences. 44:2113-2120
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de91ae2bb9e3d2906a35aff173b96249
https://doi.org/10.1007/s10072-023-06641-y
https://doi.org/10.1007/s10072-023-06641-y
Autor:
Antía Moreira, Elvira Munteis, Andrea Vera, Adrián Macías Gómez, Bernat Bertrán Recasens, Miguel Ángel Rubio Pérez, Mireia Llop, Jose E. Martínez‐Rodríguez
Background and purpose: The aim was to evaluate whether adaptive NKG2C+ natural killer (NK) cells, characterized by enhanced antibody-dependent cell cytotoxicity (ADCC), may influence time to B cell repopulation after rituximab treatment in multiple
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f8f4646a25f200b45d1e90aaf85ddb5
http://hdl.handle.net/10230/54087
http://hdl.handle.net/10230/54087
Autor:
Zabalza, Ana, Vera, Andrea, Alari-Pahissa, Elisenda, Munteis, Elvira, Antía Moreira, Yélamos, Jose, Llop, Mireia, López-Botet, Miguel, Martínez-Rodríguez, Jose E.
Additional file 1: Table 1. Proportions of B cell subsets in controls and MS patients according to HCMV serostatus.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::085716b2c3cf2de745ccfa27588c37d1
Autor:
Victor Obach, Fernando Velasco, Rocio Alvarez Escudero, María Martín Bujanda, Sonsoles Aranceta, Neus Fabregat, Teresa Marco, Aintzine Ruisanchez, Natalia Roncero, Ane Mínguez-Olaondo, Marta Ruibal, Daniel Guisado-Alonso, Antia Moreira, Elisa Cuadrado-Godia, Amaya Echeverria, Izaro Kortazar Zubizarreta, Alba López-Bravo, Nuria Riesco, Lucia González-Fernández, Nuria Pola, Paula Manera, Ángel Luis Guerrero-Peral, Agustín Oterino Duran, Yésica González-Osorio, Rosario Armand, Santiago Fernández-Fernández, David García-Azorín, Juan Carlos García-Moncó
Publikováno v:
The Journal of Headache and Pain, Vol 24, Iss 1, Pp 1-11 (2023)
Abstract Background Galcanezumab has shown efficacy and effectiveness in the treatment of episodic and chronic migraine (CM), however, the population represented in randomized clinical trials (RCTs) differs from the population observed in real-world
Externí odkaz:
https://doaj.org/article/b004166f59b241048d489a487c035582
Publikováno v:
Medicina Clínica. 154:522-523
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5067602ee6f9d27f70888cdc91413cfb
https://doi.org/10.1016/j.medcli.2019.04.034
https://doi.org/10.1016/j.medcli.2019.04.034
Publikováno v:
Medicina clinica. 154(12)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca83d86678d19cade4b562637dce7219
https://pubmed.ncbi.nlm.nih.gov/32482416
https://pubmed.ncbi.nlm.nih.gov/32482416
Autor:
Antía Moreira-Villanueva, Juan Pablo Horcajada Gallego, Robert Güerri-Fernández, Judit Villar-García
Publikováno v:
Enfermedades Infecciosas y Microbiología Clínica. 32:333-334
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b8add03cd4a4f43c8ae69c8955305d8
https://doi.org/10.1016/j.eimc.2013.07.007
https://doi.org/10.1016/j.eimc.2013.07.007